Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease

The burden and outcomes of inflammation in patients with atherosclerotic cardiovascular disease (ASCVD) are not well defined beyond the controlled settings of trials and research cohorts.